Frazier Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
Frazier Management's SNDX Position: Q4 2021 in Review
Frazier Management increased its Syndax Pharmaceuticals (SNDX) stake by 133% in Q4 2021, buying an estimated $29.3M and bringing the position to 2,772,062 shares worth $60.7M. The position accounts for 4.67% of the portfolio, ranked #4.
Frazier Management first reported a position in SNDX in Q1 2020 and has held it in 8 quarters since. 132 funds tracked by Wall St. Rank hold SNDX as of Q4 2021.
- Frazier Management held 2,772,062 shares of Syndax Pharmaceuticals worth $60.7M as of Q4 2021.
- Frazier Management bought 1,583,927 Syndax Pharmaceuticals shares in Q4 2021, an estimated $29.3M.
- Syndax Pharmaceuticals made up 4.67% of Frazier Management's portfolio in Q4 2021, its #4 holding.
- Frazier Management first reported a position in Syndax Pharmaceuticals in Q1 2020 and has held it in 8 quarters since.
- 132 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2021.
Based on Frazier Management's 13F filing for Q4 2021, filed 8 Feb 2022.